Deutsche Bank Maintains Buy on Gilead Sciences (GILD) after Strong Hepatitis C Combo Data
Go back to Deutsche Bank Maintains Buy on Gilead Sciences (GILD) after Strong Hepatitis C Combo Data| Abbott Laboratories (NYSE: ABT) | Delayed: 111.25 -0.02 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $111.27 | 52 Week High | $46.38 | |||
| Open | $111.49 | 52 Week Low | $36.00 | |||
| Day High | $111.97 | P/E | 74.17 | |||
| Day Low | $110.79 | EPS | $1.50 | |||
| Volume | 5,575,610 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 138.36 +0.22 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.14 | 52 Week High | $108.63 | |||
| Open | $136.81 | 52 Week Low | $71.39 | |||
| Day High | $138.43 | P/E | 76.44 | |||
| Day Low | $135.91 | EPS | $1.81 | |||
| Volume | 3,407,717 | |||||
